(Q47938698)

6 February 2018

title

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening (English)

1 reference

6 February 2018

0 references

1 reference

1 reference

4

1 reference

6 February 2018

author name string

Laszlo Tabar

1

1 reference

6 February 2018

Ming-Fang Yen

2

1 reference

6 February 2018

Bedrich Vitak

3

1 reference

6 February 2018

Robert A Smith

5

1 reference

6 February 2018

Stephen W Duffy

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

361

1 reference

6 February 2018

issue

9367

1 reference

6 February 2018

page(s)

1405-1410

1 reference

6 February 2018

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Breast cancer screening with mammography: overview of Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Cochrane review on screening for breast cancer with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

All-cause mortality in randomized trials of cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Re: All-cause mortality in randomized trials of cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Re: All-cause mortality in randomized trials of cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Screening mammography under age 50.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Breast screening in women aged 40-49 years: what next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Breast screening, prognostic factors and survival – results from the Swedish two county study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Age-period-cohort modelling of breast cancer incidence in the Nordic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Excess mortality from breast cancer in relation to mammography screening in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Evaluation of the effect on breast cancer mortality of population based mammography screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913143-1

7 January 2021

10.1016/S0140-6736(03)13143-1

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018